Skip to content

Gallbladder Cryoablation in High-Risk Patients

Prospective Study of Gallbladder Cryoablation in High-Risk Surgical Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04915651
Enrollment
20
Registered
2021-06-07
Start date
2021-07-01
Completion date
2023-07-01
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Colic, Biliary Dyskinesia, Cholecystitis, Gallbladder Diseases, Gall Bladder Pain, Gallstone, Gallstone; Cholecystitis

Keywords

cryoablation, gallstones, gallbladder, cholecystitis

Brief summary

Benign gallbladder disease, including acute cholecystitis, chronic cholecystitis, biliary dyskinesia, and biliary colic, is very common, with over 300,000 surgical cholecystectomies performed per year in the US. Unfortunately, complication rates in elderly patients or patients with many comorbidities are high. These patients are often managed with percutaneous tube drainage of the gallbladder (percutaneous cholecystostomy). The recurrence rate of calculous cholecystitis after cholecystostomy tube removal is as high as 35% at 1 year. These patients are thus faced with permanent cholecystostomy tube drainage, high-risk surgery, or cholecystostomy tube removal and risk of repeat cholecystitis. Gallbladder cryoablation is an alternative to surgical cholecystectomy which is performed percutaneously and does not require general anesthesia. Published evidence on the outcomes of gallbladder cryoablation is however limited at this point in time. The purpose of the proposed study is to follow the outcomes of high-risk patients who undergo gallbladder cryoablation.

Detailed description

The purpose of the proposed research is to evaluate the outcomes of gallbladder cryoablation in high-risk surgical candidates with benign gallbladder disease (acute cholecystitis, chronic cholecystitis, biliary dyskinesia, biliary colic). Specific Aim: Aim 1: To evaluate the safety and efficacy of gallbladder cryoablation in high-risk surgical candidates. Patients who undergo gallbladder cryoablation will be followed long-term according to standard of care. This includes scheduled clinic follow up, laboratory analysis, and imaging as needed. We hypothesize that gallbladder cryoablation is a safe and effective treatment for high-risk surgical patients with benign gallbladder disease. Clinically, we hypothesize that patients will be free from any clinical symptoms or signs after gallbladder cryoablation and removal of a cholecystostomy tube. These include, but are not limited to right upper quadrant pain, fever, chills, and jaundice. Aim 2: To evaluate the imaging changes seen in the gallbladder after cryoablation. Imaging is part of routine follow up after percutaneous ablation and may include CT, MRI, and nuclear medicine studies as needed. We hypothesize that after cryoablation, patients will be functionally acholecystic, which occlusion of the cystic duct and involution and fibrosis of the gallbladder demonstrated by imaging.

Interventions

DEVICEGallbladder Cryoablation

Percutaneous cryoablation of the gallbladder.

Sponsors

University of Arizona
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* High-risk surgical candidates with benign gallbladder disease who are not eligible for surgical cholecystectomy and are able to consent to study inclusion.

Exclusion criteria

* Patients with benign gallbladder disease who are eligible for surgical cholecystectomy or who are unable to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Symptomatic reliefUp to 2 years after procedureAbsence of right upper quadrant abdominal pain and nausea and absence of repeat episodes of cholecystitis, which would manifest as right upper quadrant abdominal pain associated with a fever (\>100 C) and leukocytosis.
ComplicationsUp to 2 years after procedureClavien-Dindo classification complications

Secondary

MeasureTime frameDescription
ImagingUp to 2 years after procedureImaging evidence of gallbladder devitalization and fibrosis

Countries

United States

Contacts

Primary ContactHugh McGregor, MD
hughcjmcgregor@gmail.com520-626-1069

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026